Next Article in Journal / Special Issue
Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications
Previous Article in Journal
Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future
Previous Article in Special Issue
Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
Article Menu

Export Article

Open AccessReview
Vaccines 2014, 2(4), 735-754; https://doi.org/10.3390/vaccines2040735

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 16 October 2014 11:23 CEST Version of Record https://www.mdpi.com/2076-393X/2/4/735/pdf
article xml file uploaded 14 January 2015 05:17 CET Original file https://www.mdpi.com/2076-393X/2/4/735/xml
article html file updated 14 January 2015 05:17 CET Original file -
article html file updated 20 August 2015 23:16 CEST Update -
article html file updated 22 March 2019 02:42 CET Update -
article html file updated 7 May 2019 07:03 CEST Update https://www.mdpi.com/2076-393X/2/4/735/html
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top